Clovis Oncology: Reloading Before And After Q3 Earnings For The Long Term

This post was originally published on this site

[unable to retrieve full-text content]Clovis Oncology recently reported their Q3 earnings with a beat on EPS and a miss on revenue. The company fell short and the market punished the stock for their shortcoming.